NCT05614128 - Validation of Cutaneous Nerve Demyelination in Diagnosis and Treatment of CIDP | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2023

Primary Completion Date

September 19, 2024

Study Completion Date

September 19, 2024

Conditions

CIDP

Interventions

OTHER

IVIg

Patients will be treated with IVIg as recommended by expert guidelines for treatment of CIDP under care of their primary neurologist. This will not be provided by the study.

Trial Locations (1)

37232

Peltier Amanda, Nashville